Skip to main content

Greenland Mines Expands European Investor Access with Frankfurt Stock Exchange Listing

Frankfurt listing complements Nasdaq presence and advances the Company’s North Atlantic Critical Metals Corridor strategy CHARLOTTE, N.C., Sept. 25, 2026 (GLOBE NEWSWIRE) — via IBN – Greenland Mines Ltd (“Greenland Mines” or the “Company”) (Nasdaq: GRML; FSE: HK6), a Greenland-focused mineral resource development company, today announced that its common shares are now listed and trading on the Frankfurt Stock Exchange (“FSE”) under the symbol HK6. The listing provides European investors with an additional venue to access Greenland Mines shares and complements the Company’s principal Nasdaq listing. No new shares are being issued in connection with the Frankfurt listing. “Greenland Mines is building a transatlantic critical-minerals company, and Frankfurt is a natural next step,” said Bo Møller Stensgaard, President of Greenland...

Continue reading

Pharming announces U.S. FDA acceptance and Priority Review of sNDA for lower doses of Joenja® to treat children with APDS

If approved, Joenja would be available to eligible patients aged 4 years and older with APDS who weigh 13 kg or more Decision follows recent approval of Joenja for children aged 4 to 11 years with APDS weighing at least 27 kg PDUFA target action date of January 30, 2027Leiden, the Netherlands, September 25, 2026: Pharming (Euronext Amsterdam: PHARM/Nasdaq: PHAR), a global biotechnology company focused on rare immune and genetic diseases, today announced that the U.S. Food and Drug Administration (FDA) has accepted its supplemental New Drug Application (sNDA) seeking approval for lower doses of Joenja® (leniolisib), an oral, selective phosphoinositide 3-kinase delta (PI3Kδ) inhibitor, for children aged 4 years and older who weigh between 13 kg and 27 kg with activated phosphoinositide 3-kinase delta syndrome (APDS), a rare primary immunodeficiency....

Continue reading

From Warehouses to Sidewalks: Seyond Scales LiDAR for the Next Generation of Robotics

At IROS 2026, Seyond will showcase how premium, production-ready LiDAR is supporting robotics as autonomous systems move from specialized applications toward broader real-world deploymentSUNNYVALE, Calif., Sept. 25, 2026 (GLOBE NEWSWIRE) — As the global robotics community gathers for the 2026 IEEE/RSJ International Conference on Intelligent Robots and Systems (IROS), Seyond is highlighting a transformation already taking place beyond the research lab: robots are becoming an increasingly practical part of everyday life. Across hospitals, warehouses, sidewalks, and commercial spaces, robots are taking on a growing range of real-world tasks. As the industry moves from prototypes and limited deployments toward broader commercialization, the challenge is no longer simply proving that a robot can navigate autonomously. It is doing...

Continue reading

Knight Therapeutics Inc. places No. 345 on The Globe and Mail’s eighth annual ranking of Canada’s Top Growing Companies

MONTREAL, Sept. 25, 2026 (GLOBE NEWSWIRE) — Knight Therapeutics Inc. (TSX:GUD) (“Knight” or “the Company”) is pleased to announce it has ranked No. 345 on the 2026 Report on Business magazine’s ranking of Canada’s Top Growing Companies. Canada’s Top Growing Companies ranks Canadian companies on three-year revenue growth. Knight earned its spot with three-year growth of 53%. “We’re honored to be recognized as one of Canada’s Top Growing Companies by Report on Business for the sixth consecutive year,” said Samira Sakhia, President and CEO of Knight. “This recognition belongs to our team across Canada and Latin America. Their focus and disciplined execution continue to drive Knight’s growth. We remain committed to bringing innovative products to physicians and improving the health of the patients they serve. With over 50 product...

Continue reading

BioSyent Named as One of Canada’s Top Growing Companies 2026 by The Globe and Mail

MISSISSAUGA, Ontario, Sept. 25, 2026 (GLOBE NEWSWIRE) — BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) is pleased to announce that it has been named as one of Canada’s Top Growing Companies for 2026 by The Globe and Mail’s Report on Business magazine. BioSyent ranked 343 on the list based on its three-year revenue growth of 54% (2022 – 2025) and is listed in the ‘Consumer’ category. “We are very proud to have been recognized as one of Canada’s Top Growing Companies,” said René Goehrum, President and CEO of BioSyent. “With the support of our team and the continued trust of patients and healthcare providers, we have continued to execute on one of BioSyent’s key strategic priorities of profitable growth, with Q2 2026 marking the 64th consecutive profitable quarter for the Company.” The full 2026 ranking of Canada’s Top...

Continue reading

Fangzhou Releases 2026 Interim Report, Deepening “AI + Chronic Care” as a Lifetime Health Service Partner

SHANGHAI, China, Sept. 25, 2026 (GLOBE NEWSWIRE) — Fangzhou Inc. (“Fangzhou” or the “Company”) (HKEX: 06086), a leading provider of AI‑driven Internet healthcare solutions, has released its 2026 interim report, highlighting continued progress in its “AI + Chronic Disease Services” strategy as the Company advances its positioning as a full-lifecycle personal health service partner. In the first half of 2026, Fangzhou recorded revenue of RMB1.8245 billion, up 22.2% year-on-year, while adjusted net profit increased 6.4% to RMB18.7 million. The Company’s cumulative registered users exceeded 59.8 million, with average monthly active users rising 23.1% to 14.7 million. Its network of registered physicians expanded to 282,000. Fangzhou continued to accelerate the deployment of AI across chronic disease services, addressing persistent challenges...

Continue reading

Oma Savings Bank Plc issues a covered bond of EUR 200 million as part of a bond program

Oma Savings Bank Plc, stock exchange release, 25 September 2026 at 4.30 p.m. (EEST), other information disclosed to the rules of the exchange Oma Savings Bank Plc issues a covered bond of EUR 200 million as part of a bond program NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, HONG KONG, JAPAN, NEW ZEALAND, SINGAPORE, SOUTH AFRICA OR SUCH OTHER COUNTRIES OR OTHERWISE IN SUCH CIRCUMSTANCES IN WHICH THE OFFERING OF THE NEW NOTES, THE TENDER OFFER OR THE RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. Oma Savings Bank Plc (“OmaSp” or the “Company”) issues a covered bond of EUR 200 million. The maturity date of the bond is 2 October 2029, and the loan has a floating interest rate. The ISIN code of the bond is FI4000615059. The loan issuance...

Continue reading

SBC Medical to Participate in Several Upcoming Investor Conferences in October 2026

IRVINE, Calif., Sept. 25, 2026 (GLOBE NEWSWIRE) — SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“The Company” or “SBC Medical”), a Medical Services Organization (MSO) providing management support across a wide range of healthcare fields, today announced its participation in several upcoming investor conferences in October 2026. SBC Medical will conduct presentations and one-on-one meetings with institutional investors. Below is a summary of the Company’s scheduled participation in upcoming investor conferences: Noble Capital Markets October 2026 Emerging Growth Virtual Equity ConferenceDate: October 1-2, 2026Format: VirtualRegistration: Link Maxim Growth Summit 2026Date: October 14, 2026Format: In-person (New York)Registration: Link The ThinkEquity Conference 2026Date: October 15, 2026Format: In-person (New York)Registration:...

Continue reading

Kodiak AI Names Dallas-Houston As Long-Haul Driverless Launch Lane, Consistently Completes Intervention-Free, End-to-End Deliveries

Another full daytime run on Dallas–Houston, now officially our first driverless long-haul lane. From our Lancaster hub to Houston, 219 miles on I-45 and the surface streets on either end, the Kodiak Driver handled every mile without a human touching the wheel.We’ve been running this lane daily since August as part of our final validation before driver-out operations. Driverless long-haul launches here by the end of the year.Learn more at kodiak.aiKodiak on target to complete its safety case validation and begin unsupervised driverless highway service by year end Under Kodiak’s driverless launch program, the company is conducting daily preparation runs along Interstate 45, as well as driverless validation testing at closed-course test tracks MOUNTAIN VIEW, Calif., Sept. 25, 2026 (GLOBE NEWSWIRE) — Kodiak...

Continue reading

Tilray Brands to Announce First Quarter Fiscal Year 2027 Financial Results on October 8, 2026

NEW YORK and LONDON and LEAMINGTON, Ontario, Sept. 25, 2026 (GLOBE NEWSWIRE) — Tilray Brands, Inc. (“Tilray” or the “Company”) (Nasdaq: TLRY; TSX: TLRY), a global lifestyle and consumer packaged goods company at the forefront of the cannabis, beverage, hospitality and wellness industries, today announced that the Company will release its financial results for the first fiscal quarter ended August 31, 2026, before the financial markets open on Thursday, October 8, 2026. Live Conference Call and Audio Webcast Tilray will host a live conference call, which will be webcast, to discuss these results at 8:30 AM Eastern Time on the same day. The webcast can be accessed on the Events & Presentations section of Tilray’s Investor Relations website. About Tilray Brands Tilray Brands, Inc. (“Tilray”) (Nasdaq: TLRY; TSX: TLRY), is a leading...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.